Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: FDA Issues CRL to Elevar Therapeutics
In today's Pharmaceutical Executive Daily, a new industry analysis warns that direct-to-patient pharma platforms are scaling faster than the safety i…
9 hours ago
Pharmaceutical Executive Daily: FDA Approves Subcutaneous Sarclisa Escena
In today's Pharmaceutical Executive Daily, FDA quietly pauses its real-time public release of complete response letters, FDA approves Sanofi's Sarcli…
3 days, 11 hours ago
Pharmaceutical Executive Daily: FDA Approves Ennumo
In today's Pharmaceutical Executive Daily, FDA approves Ennumo, a pharma roundup covers Chemomab Therapeutics' merger with AI-enabled precision medic…
4 days, 11 hours ago
“AI as Reinvention”: Transforming the Business of Medicine
In this episode of the Pharm Exec podcast, Emmanuel Frenehard, executive vice president and chief digital officer at Sanofi, shares how one of the w…
5 days, 15 hours ago
Pharmaceutical Executive Daily: The Changing Reality of Pharmaceutical Commercialization
6 days, 9 hours ago
Pharmaceutical Executive Daily: The Medicare GLP-1 Bridge
In today's Pharmaceutical Executive Daily, AlzeCure Pharma announces a collaboration with QuantumCell ApS worth more than $2.2 billion for global rig…
1 week, 5 days ago
Pharmaceutical Executive Daily: FDA Names Seven Participants to Precheck Program
In today's Pharmaceutical Executive Daily, FDA selects seven companies for its new PreCheck Pilot Program, Kirsten Whipple examines how the concept o…
1 week, 6 days ago
Pharmaceutical Executive Daily: Ipsen Enters Merger Agreement to Acquire Kartos Therapeutics
In today's Pharmaceutical Executive Daily, a pharma M&A roundup covers Ipsen's up to $1.75 billion acquisition of Kartos Therapeutics and Zymeworks' …
2 weeks ago
Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
2 weeks, 4 days ago